PATENT CLAIM ANALYSIS

Application Number: 16128421
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "277100"]

Abstract:
Disclosed herein is a system and methods for determining the alleles, neoantigens, and vaccine composition as determined on the basis of an individual's tumor mutations. Also disclosed are systems and methods for obtaining high quality sequencing data from a tumor. Further, described herein are systems and methods for identifying somatic changes in polymorphic genome data. Finally, described herein are unique cancer vaccines.

Claim (Index 13):
The method of  claim 1 , wherein the set of presentation likelihoods are further identified by at least allele interacting features, comprising at least one of:\n (a) predicted affinity between a neoantigen in the set of neoantigens and the one or more MEW alleles; and (b) predicted stability of the neoantigen encoded peptide-MHC complex.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.47917
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15466729', '15210489', '15170919', '13640989', '15791301']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7306575199935412
- 35 USC 102 Novelty (BERT): 0.6856067732804652
- Combined Prediction Score: 0.7261524453222337
- Mean Citation Score: 388.519416
- Max Citation Score: 745.2901
- Similarity Product: 677.9902975686252

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test